The prevalence of thyroid tumors in patients with acromegaly

Aim.

To study the incidence of thyroid tumors in patients with acromegaly in comparison with the control group (1:2,5).

Materials and methods.

The study included 125 patients with acromegaly: 85 women and 40 men. Mean age 51,31 [23;78]. The control group included of 324 people: 228 women and 96 men. Mean age group 49 [24;80]. All were performed ultrasound. If there is evidence in both groups performed FNA, followed by cytological examination. In patients with acromegaly were investigated levels of growth hormone and IGF-1, TSH and FT4. In the control group of TSH and FT4.

Results.

Thyroid diseases are comparable between the study groups by sex: nodular goiter frequently diagnosed in females, and mixed and diffuse goiters in males. Thyroid cancer has also been reported more often in men in both groups. However, it should be noted that the incidence of thyroid cancer in patients with acromegaly exceeded the figures of the control group 3,05 times, namely: nodular goiter 1.69 times (р = 0.05), diffuse goiter 2.32 times (р = 0.01), mixed goiter 5,96 times (р < 0.01). The incidence of thyroid cancer has exceeded the values of the control group 6,05 times. These results gave an odds ratio of 6.68 (95%CI 2.5 to 17.82), р = 0.0001. Dependencies between the level of IGF-1 (p = 0.84), disease duration (p = 0.69), age (p = 0.86) and the risk of developing cancer have been identified.

Conclusion.

The results indicate an increased risk of thyroid disease in patients with acromegaly in general and cancer in particular, that necessitates more frequent monitoring thyroid condition in patients with acromegaly, especially in males, independent of the level of IGF-1, the duration of the disease and age.

1. Mercado M, Gonzalez B, Vargas G, et al. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab. 2014;99(12):4438-4446. doi: 10.1210/jc.2014-2670.

2. Webb SM, Casanueva F, Wass JaH. Oncological complications of excess GH in acromegaly. Pituitary. 2002;5(1):21-25. doi: 10.1023/a:1022149300972.

3. Baldvinsdottir T, Jonasson JG, Thorsson AV, et al. Epidemiology of pituitary tumorous in Iceland 1955-2007: a Nationwide study. Endocrine Abstracts. Proceedings of 10th European Congress of Endocrinology;2008 May 3-7; Berlin, Germany.

4. Bates AS, Van’t Hoff W, Jones JM, et al. Does treatment of acromegaly affect life expectancy? Metabolism. 1995;44:1-5. doi: 10.1016/0026-0495(95)90303-8.

5. Orme SM, Mcnally RJQ, Cartwright RA, et al. Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab. 1998;83(8):2730-2734. doi: 10.1210/jcem.83.8.5007.

6. Ron E, Gridley G, Hrubec Z, et al. Acromegaly and gastrointestinal cancer. Cancer. 1991;68(8):1673-1677. doi: 10.1002/ 1097-0142(19911015)68:8<1673::aid-cncr2820680802>3.0.co;2-0.

7. Jenkins PJ, Besser M. Clinical perspective: Acromegaly and cancer: A problem. J Clin Endocrinol Metab. 2001;86(7):2935-2941. doi: 10.1210/jcem.86.7.7634.

8. Uchoa HBDMP, Lima GaB, Corrêa LL, et al. Prevalence of thyroid diseases in patients with acromegaly: Experience of a brazilian center. Arquivos Brasileiros de Endocrinologia & Metabologia. 2013;57(9):685-690. doi: 10.1590/s0004-27302013000900003.

9. Dąbrowska AM, Tarach JS, Kurowska M, et al. State of the art paper thyroid diseases in patients with acromegaly. Arch Med Sci. 2014;4:837-845. doi: 10.5114/aoms.2013.36924.

10. Dos Santos MCC, Nascimento GC, Nascimento AGC, et al. Thyroid cancer in patients with acromegaly: A case-control study. Pituitary. 2012;16(1):109-114. doi: 10.1007/s11102-012-0383-y.

11. Khamseh ME, Wolinski K, Czarnywojtek A, et al. Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly – meta-analysis and systematic review. PLoS ONE. 2014;9(2):e88787. doi: 10.1371/journal.pone.0088787.

12. Валдина Е.А. Заболевания щитовидной железы. Руководcтво. – СПб.: Питер; 2005. [Valdina EA. Zabolevaniya shchitovidnoi zhelezy. Rukovodstvo. St.Petersburg: Piter; 2005. (In Russ).]

13. Мерабишвили В.М. Онкологическая служба в Санкт-Петербурге и районах города в 2005 году. – СПб; 2006. [Merabishvili VM. Onkologicheskaya sluzhba v Sankt-Peterburge i raionakh goroda v 2005 godu. Sankt-Peterburg; 2006. (In Russ).]

14. Чиссов В.И., Стравинский В.В. Злокачественные новообразования в России в 2000 году. – М.: МНИОИ им. П.А.Герцена; 2002. [Chissov VI, Stravinskii VV. Zlokachestvennye novoobrazovaniya v Rossii v 2000 godu. Moscow: MNIOI im. P.A.Gertsena; 2002. (In Russ).]